Ascend Wellness Holdings, Inc. (OTC:AAWH – Free Report) – Analysts at Atb Cap Markets provided Q2 2024 EPS estimates for Ascend Wellness stock in a report published on Tuesday, May 7th. Atb Cap Markets analyst F. Gomes expects the company to post earnings per share of $0.06 for the current quarter. Ascend Wellness’ current consensus estimate for full-year earnings is $0.15 per share. Atb Cap Markets also reports that Ascend Wellness’ 2024 Q3 earnings are ($0.06) EPS, 2024 Q4 earnings are ($0.05) EPS, 2024 earnings are ($0.26) EPS, and 2025 earnings are ($0.26) EPS. The company also announced an EPS of ($0.16) and a forecast for FY2028 profit of ($0.08). EPS.
Separately, Needham & Company LLC reiterated a “hold” rating on shares of Ascend Wellness in a research note on Tuesday.
Check out the latest report on AAWH.
Ascend Wellness Price Performance
Ascend Wellness stock opened Friday at $1.30. The company’s 50-day moving average is $1.27 and its 200-day moving average is $1.27. Ascend Wellness has a 1-year low of $0.46 and a 1-year high of $1.82. The company has a debt-equity ratio of 2.08, a quick ratio of 1.44, and a current ratio of 2.47.
Ascend Wellness Company Profile
(Get Free Report)
Ascend Wellness Holdings, Inc is engaged in the cultivation, manufacturing and distribution of cannabis consumer packaged goods in the United States. The company sells flower, pre-rolls, concentrates, vapes, edibles, tinctures and other cannabis products under Common Goods, Simply Herbs, Ozone, Ozone Reserve, Royal, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, and 1906. We provide related products. , AiroPro brand.
Related item
Receive daily Ascend Wellness news and reviews – Enter your email address below to receive a concise, daily summary of the latest news and analyst ratings for Ascend Wellness and related companies in MarketBeat.com’s free daily email newsletter.
